依那普利联合碳酸钙D3治疗老年高血压合并骨质疏松的效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (41 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo observe the effect of Enalapril combined with calcium carbonate vitamine D3on bonemineral density(BMD)of the elderly patientswith essential hypertension and osteoporosis.MethodsFrom May 2014 to December 2015,a total of 63 elderly patients with essential hypertension and osteoporosis in our hospital were selected as study object and randomly and double-blindly divided into group A(n=32)treated by Enalaprilwith calcium carbonate vitamine D3and group B (n=31)without Enalapril.The two groupswere observed for one year,the levels of 25-OH-vitamin D,serum calcium(Ca2+),serum phosphorus(P),alkaline phosphatase(ALP),parathyroid hormone(PTH),osteocalcin weremeasured before and 3,6,9,12 months after treatment.Bonemineral density (BMD)of lumbar vertebrae and neck weremeasured before and after treatment.ResultsThere was no significant difference in baseline values of serum parameters between two groups(P＞0.05).The total serum 25-OH-vitamin D levels in two groupswere increased 12months after treatment,and which 9 and 12months after treatmentwas significantly higher than the baseline values,however,the levels of 25-OH-vitamin D in two groupswere lower than normal value(30 ng/ml),there was no significnt statistical difference in the levels of 25-OH-vitamin D between two groups(P＞0.05).12months after treatment,serum Ca2+levels of two groups were elevated and within the normal range,no hypercalcemia occurred;serum Ca2+levels of two groups 6,9 and 12 months after treatment compared to the baseline valueswere significantly increased(P＜0.05);there was no statistically significant difference in serum Ca2+levels oftwo groups (P＞0.05).Osteocalcin,PTH,ALP,P compared with baseline values did not change significantly,there was no significant difference between two groups(P＞0.05).BMD(L1-4)value after treatment for one year in group A was significantly higher than that before treatment(P＜0.01);BMD value after treatment for one year in B group compared with before treatment had no obvious change (P＞0.05);after treatment for one year,BMD (L1-4)between two groupswere compared,and the difference was statistically significant(P＜0.05).BMD (neck)values after treatment for one year in two groupswere no higher than before,and there was no statistical difference in BMD(neck)between two groups(P＞0.05).ConclusionBMD value was obviously increased in the elderly patientwith essential hypertension and osteoporosiswho have taken Enalapril and calcium carbonate vitamine D3after treatment for one year.

Key words： Essential hypertension Osteoporosis Bonemineral density Enalapril

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Ping-jun
	WANG Xia
	HUANG Xiao-hong

Cite this article:

CHEN Ping-jun,WANG Xia,HUANG Xiao-hong. Effect of Enalapril combined with calcium carbonate vitam ine D3on bone m ineraldensity ofelderly patientswith essentialhypertension and osteoporsis[J]. 中国当代医药, 2016, 23(34): 28-31.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2016/V23/I34/28

[1]	张新军.肾素-血管紧张素系统拮抗剂在高血压治疗中的应用[J].心血管病学进展，2015，36（6）：673-676.
[2]	中国高血压防治指南修订委员会.中国高血压防治指南（2010）[J].中国医学前沿杂志（电子版），2011，3（5）：42-93.
[3]	徐君翔，刘晨，张鹏，等.高血压与中老年女性骨密度的关系[J].中国老年学杂志，2015，35（6）：872-875.
[4]	史大治，王曦云，宋成伟.中老年男性高血压病与骨质疏松的关系[J].中国实用医药，2012，7（18）：55-56.
[5]	和渝斌，王波，刘立新，等.长效钙拮抗剂对高龄老年男性高血压患者骨密度及骨折发生率的影响[J].中华临床医师杂志（电子版），2012，6（18）：5703-5704.
[6]	李霞绯，吴娟.依那普利和替米纱坦对绝经后原发性高血压女性患者骨密度及骨转化的影响[J].中国药房，2013，24（48）：4534-4536.
[7]	王宇，徐颖颖，张相彩，等.钙离子拮抗剂类降压药的临床应用及不良反应[J].中国现代应用药学，2015，32（3）：385-390.
[8]	杨军，王博，宣淼，等．降压药对老年女性高血压患者骨密度的影响[J].老年医学与保健，2011，17（2）：92-94.
[9]	刘颖，宋成伟，杜以武.老年人原发性高血压与骨密度及骨代谢失调的相关性研究[J].中国实验诊断学，2014，18 （10）：1689-1690.
[10]	廖梦阳，程龙献，廖玉华.肾素-血管紧张素系统的回顾[J].临床心血管病杂志，2012，28（2）：83-87.
[11]	柏松.新型肾素-血管紧张素系统治疗高血压的研究进展[J].中国当代医药，2016，23（16）：19-21.
[12]	蔡晓娜，屈百鸣.以肾素-血管紧张素-醛固酮系统为靶点的高血压治疗新方法[J].中西医结合心脑血管病杂志，2015，13（1）：63-67.
[13]	张方怡，Yoseph G，黄文秀，等.肾素抑制剂阿利吉仑对低钙喂饲小鼠松质骨的作用[J].中国药理学通报，2014，30（10）：1477-1478.
[14]	谢军，孙媛媛，张颖，等.老年高血压患者血压变异性与骨质疏松的相关性研究[J].安徽医学，2014，35（2）：146-148.
[15]	王烨明.抗高血压药与骨质疏松症[J].中国骨质疏松杂志，2016，22（9）：1184-1187.
[16]	钟奕，薛青，周奕，等.培哚普利对维甲酸所致骨质疏松模型大鼠骨代谢的影响[J].中国组织工程研究，2016，20 （18）：2589-2602.
[17]	帅波，沈霖、杨艳萍，等.血管紧张素转换酶抑制剂对去卵巢骨质疏松小鼠骨组织结构的影响[J].中华骨质疏松和骨矿盐疾病杂志，2015，8（3）：229-235.
[18]	黄慧，梁桃.抗高血压药对骨质疏松的影响[J].内蒙古中医药，2014，33（2）：42-43.